Abstract
A novel phenolate-bridged binuclear copper(II) complex, [Cu II2 (L–3H)Cl] (1, where L = 2,6-bis[((2-hydroxybenzyl)(2-pyridylmethyl)amino)methyl]-4-methylphenol), have been synthesized and characterized. The antiproliferative activity of the complex has been tested in vitro against the human cervical cancer cell line HeLa, human non-small-cell lung cancer cell line A-549, the human breast cancer cell line MCF-7, and the human hepatic cell line LO2. The results show the complex has the low micromolar range (9.4–11.2 µM) of IC50 values towards the three cancer cell lines, which is markedly comparable to those of cisplatin. However 1 exhibited 10.6-fold less toxicity than cisplatin toward normal cells LO2, suggesting that complex 1 had high selectivity between tumor cells and normal cells. The interactions with DNA were investigated by UV–Vis absorption, fluorescence, circular dichroism, and gel electrophoresis. The results show that the copper(II) complex could strongly bind to DNA mainly by the groove binding mode and efficiently cleave the pBR322 plasmid DNA into its nicked and linear forms in the presence of excessive ascorbic acid. In addition, the evaluation of the protein binding ability shows that complex 1 could bind to human serum albumin (HSA) with a moderate binding affinity and quench the intrinsic fluorescence of HSA.
Similar content being viewed by others
References
Abou-Zied OK, Al-Shihi OIK (2008) Characterization of subdomain IIA binding site of human serum albumin in its native, unfolded, and refolded states using small molecular probes. J Am Chem Soc 130:10793–10801
Alagesan M, Bhuvanesh NSP, Dharmaraj N (2014) Binuclear copper complexes: synthesis, X-ray structure and interaction study with nucleotide/protein by in vitro biochemical and electrochemical analysis. Eur J Med Chem 78:281–293
Alley MC, Scudiero DA, Monks A, Hursey ML, Czerwinski MJ, Fine DL, Abbott BJ, Mayo JG, Shoemaker RH, Boyd MR (1988) Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res 48:589–601
Baguley BC, LeBret M (1984) Quenching of DNA-ethidium fluorescence by amsacrine and other antitumor agents: a possible electron-transfer effect. Biochemistry 23:937–943
Bi SY, Song DQ, Tian Y, Zhou X, Liu ZY, Zhang HQ (2005) Molecular spectroscopic study on the interaction of tetracyclines with serum albumins. Spectrochim Acta Part A 61:629–636
Biswas N, Khanra S, Sarkar A, Bhattacharjee S, Manda DP, Chaudhuri A, Chakraborty S, Choudhury CR (2017) One new azido bridged dinuclear copper(II) thiosemicarbazide complex: synthesis, DNA/protein binding, molecular docking study and cytotoxicity activity. New J Chem 41:12996–13011
Bloomfield VA, Crothers DM, Tinoco I (1974) Physical chemistry of nucleic acids. Harper and Row, New York, p 432
Chen ZF, Zhang J, Zhang SP (2015) Oxidative DNA cleavage promoted by two phenolate-bridged binuclear copper(II) complexes. New J Chem 39:1814–1821
da Silveira VC, Luz JS, Oliveira CC, Graziani I, Ciriolo MR, da Costa Ferreira AM (2008) Double-strand DNA cleavage induced by oxindole-schiff base copper(II) complexes with potential antitumor activity. J Inorg Biochem 102:1090–1103
Denoyer D, Masaldan S, La Fontaine S, Cater MA (2015) Targeting copper in cancer therapy: ‘copper that cancer’. Metallomics 7:1459–1476
Eftink MR, Ghiron CA (1976) Fluorescence quenching of indole and model micelle systems. J Phys Chem 80:486–493
Frey ST, Sun HHJ, Murthy NN, Karlin KD (1996) A new trinuclear copper complex and its reactions with plasmid DNA. Inorg Chem Acta 242:329–338
Ganeshpandian M, Ramakrishnan S, Palaniandavar M, Suresh E, Riyasdeen A, Akbarsha MA (2014) Mixed ligand copper(II) complexes of 2,9-dimethyl-1,10-phenanthroline: tridentate 3N primary ligands determine DNA binding and cleavage and cytotoxicity. J Inorg Biochem 140:202–212
Gao WH, Li NN, Chen YW, Xu YP, Lin YJ, Yin YG, Hu ZD (2010) Study of interaction between syringing and human serum albumin by multi-spectroscopic method and atomic force microscopy. J Mol Struct 983:133–140
Geary WJ (1971) The use of conductivity measurements in organic solvents for the characterization of coordination compounds. Coord Chem Rev 7:81–122
Groessl M, Terenghi M, Casini A, Elviri L, Lobinski R, Dyson PJ (2010) Reavtivity of anticancer metallodrugs with serum proteins: new insights from size exclusion chromatography-ICP-MS and ESI-MS. J Anal At Spectrom 25:305–313
Haworth IS, Elcock AH, Freeman J, Rodger A, Richards WG (1991) Sequence selective binding to the DNA major groove: tris(1,10-phenanthronline) metal complexes binding to poly(dG-dC) and poly(dA-dT). J Biomol Struct Dyn 9:23–43
He XM, Carter DC (1992) Atomic structure and chemistry of human serum albumin. Nature 358:209–215
Hu W, Luo Q, Wu K, Li X, Wang F, Chen Y, Ma X, Wang J, Liu J, Xiong S, Sadler PJ (2011) The anticancer drug cisplatin can cross-link the interdomain zinc site to human albumin. Chem Commun 47:6006–6008
Iakovidis I, Delimaris I, Piperakis SM (2011) Copper and its complexes in medicine: a biochemical approach. Mol Biol Int 2011:594529
Ibrahim N, Ibrahim H, Kim S, Nallet JP, Nepveu F (2010) Interactions between antimalarial indolone-N-oxide derivatives and human serum albumin. Biomacromolecules 11:3341–3351
Jamieson ER, Lippard SJ (1999) Structure, recognition, and processing of cisplatin-DNA adducts. Chem Rev 99:2467–2498
Jin Y, Cowan JA (2005) DNA cleavage by copper-ATCUN complexes. Factors influencing cleavage mechanism and linearization of dsDNA. J Am Chem Soc 127:8408–8415
Johnson JR (1994) CD of nucleic acids. In: Nakanishi K, Berova N, Woody RW (eds) Circular dichroism: principles and applications. VCH, New York, pp 523–540
Kelland L (2007) The resurgence of platinum-based cancer chemotherapy. Nat Rev Cancer 7:573–584
Kellett A, O’Connor M, McCann M, Howe O, Casey A, McCarron P, Kavanagh K, McNamara M, Kennedy S, May DD, Skell PS, O’Shea D, Devereux M (2011) Water-soluble bis(1,10-phenanthroline) octanedioate Cu2+ and Mn2+ complexes with unprecedented nano and picomolar in vitro cytotoxicity: promising leads for chemotherapeutic drug development. Med Chem Commun 2:579–584
Kim BE, Nevitt T, Thiele DJ (2008) Mechanisms for copper acquisition, distribution and regulation. Nat Chem Biol 4:176–185
Krebs B, Schepers K, Bremer B, Henkel G, Althaus E, Müller-Warmuth W, Griesar K, Haase W (1994) Model compounds for the oxidized uteroferrin-phosphate complex with novel dinucleating ligands containing phenolate and pyridine donors. Inorg Chem 33:1907–1914
Kurtz DM (1990) Oxo- and hydroxo-bridged diiron complexes: a chemical perspectivie on a biological unit. Chem Rev 90:585–606
Lahiri D, Bhowmick T, Pathak B, Shameema O, Patra AK, Ramakumar S, Chakravarty AR (2009) Anaerobic photocleavage of DNA in red light by dicopper(II) complexes of 3,3′-dithiodipropionic acid. Inorg Chem 48:339–349
Laitinen OH, Hytonen VP, Nordlund HR, Kulomaa MS (2006) Genetically engineered avidins and streptavidins. Cell Mol Life Sci 63:2992–3017
Lakowicz JR, Weber G (1973) Quenching of fluorescence by oxygen. A probe for structural fluctuations in macromolecules. Biochemistry 12:4161–4170
Li XW, Li YT, Wu ZY, Yan CW (2012) Syntheses and structures of bicopper(II) complexes bridged by N-(5-chloro-2-hydroxyphenyl)-N′-[3-(dimethylamino)propyl]oxamide: cytotoxic activities, and reactivities towards DNA and protein. Inorg Chim Acta 390:190–198
Li DD, Zhang N, Dai LL, Yang ZB, Tao ZW (2016) Synthesis, DNA binding, nuclease activity and cytotoxic studies of a wheel-shaped octanuclear copper(II) complex based on 1,2,4-triazole. Appl Organometal Chem 30:346–353
Lian WJ, Wang XT, Xie CZ, Tian H, Song XQ, Pan HT, Qiao X, Xu JY (2016) Mixed-ligand copper(II) schiff base complexes: the role of the co-ligand in DNA binding, DNA cleavage, protein binding and cytotoxicity. Dalton Trans 45:9073–9087
Lin XD, Liu YH, Xie CZ, Bao WG, Shen J, Xu JY (2017) Three Pt(II) complexes based on thiosemicarbazone: synthesis, HSA interaction, cytotoxicity, apoptosis and cell cycle arrest. RSC Adv 7:26478–26486
Maity B, Roy M, Saha S, Chakravarty AR (2009) Photoinduced DNA and protein cleavage activity of ferrocene-conjugated ternary copper(II) complexes. Organometallics 28:1495–1505
Malati MA (1999) Experimental inorganic/physical chemistry. Woodhead Publishing, Cambridge
Marmur J (1961) A procedure for the isolation of deoxyribonucleic acid from micro-organisms. J Mol Biol 3:208–218
Marzano C, Pellei M, Tisato F, Santini C (2009) Copper complexes as anticancer agents. Anti-Cancer Agents Med Chem 9:185–211
Mazuryk O, Niemiec E, Stochel G, Gillaizeau I, Brindell M (2013) Benzothiophen-pyrazine scaffold as a potential membrane targeting drug carrier. J Lumin 140:51–56
Meyer-Almes FJ, Porschke D (1993) Mechanism of intercalation into the DNA double helix by ethidium. Biochemstry 32:4246–4253
Mirica LM, Ottenwaelder X, Stack TDP (2004) Structure and spectroscopy of copper-dioxygen complexes. Chem Rev 104:1013–1045
Pasternack RF, Caccam M, Keogh B, Stephenson TA, Williams AP, Gibbs EJ (1991) Studies on the binding of pepstatin and its derivatives to rhizopus pepsin by quantum mechanics, molecular mechanics, and free energy perturbation methods. J Am Chem Soc 113:6835–6840
Qi JX, Liang SC, Gou Y, Zhang ZL, Zhou ZP, Yang F, Liang H (2015) Synthesis of four binuclear copper(II) complexes: structure, anticancer properties and anticancer mechanism. Eur J Med Chem 96:360–368
Raja DS, Bhuvanesh NSP, Natarajan K (2011) Biological evaluation of a novel water soluble sulphur bridged binuclear copper(II) thiosemicarbazone complex. Eur J Med Chem 46:4584–4594
Raja DS, Bhuvanesh NSP, Natarajan K (2012) DNA binding, protein interaction, radical scavenging and cytotoxic activity of 2-oxo-1,2-dihydroquinoquinoline-3-carbaldehyde(2′-hydroxybenzoyl)hydrazone and its Cu(II) complexes: a structure activity relation study. Inorg Chim Acta 385:81–93
Reichmann ME, Rice SA, Thomas CA, Doty P (1954) A further examination of the molecular weight and size of desoxypentose nucleic acid. J Am Chem Soc 76:3047–3053
Ruiz-Azuara L, Bravo-Gómez ME (2010) Copper compounds in cancer chemotherapy. Curr Med Chem 17:3606–3615
Samari F, Hemmateenejad B, Shamsipur M, Rashidi M, Samouei H (2012) Affinity of two novel five-coordinated anticancer Pt(II) complexes to human and bovine serum albumins: a spectroscopic approach. Inorg Chem 51:3454–3464
Santini C, Pellei M, Gandin V, Porchia M, Tisato F, Marzano C (2014) Advances in copper complexes as anticancer agents. Chem Rev 114:815–862
Sheng X, Lu XM, Chen YT, Lu GY, Zhang JJ, Shao Y, Liu F, Xu Q (2007) Synthesis, DNA-binding, cleavage, and cytotoxic activity of new 1,7-dioxa-4,10-diazacyclododecane artificial receptors containing bisguanidinoethyl or diaminoethyl double side arms. Chem Eur J 13:9703–9712
Shi SY, Zhang YP, Chen XQ, Peng MJ (2011) Investigation of flavonoids bearing different substituents on ring C and their Cu2+ complex binding with bovine serum albumin: structure-affinity relationship aspects. J Agric Food Chem 59:10761–10769
Tabassum S, Al-Asbahy WM, Afzal M, Arjmand F, Khan RH (2012) Interaction and photo-induced cleavage studies of a copper based chemotherapeutic drug with human serum albumin: spectroscopic and molecular docking study. Mol BioSyst 8:2424–2433
Tisato F, Marzano C, Porchia M, Pellei M, Santini C (2010) Copper in diseases and treatments, and copper-based anticancer strategies. Med Res Rev 30:708–749
Tolia C, Papadopoulos AN, Raptopoulou CP, Psycharis V, Garino C, Salassa L, Psomas G (2013) Copper(II) interacting with the non-steroidal anti-inflammatory drug flufenamic acid: structure, antioxidant activity and binding to DNA and albumins. J Inorg Biochem 123:53–65
Tysoe SA, Morgan RJ, Baker AD, Strekas TC (1993) Spectroscopic investigation of differential binding modes of Δ- and Λ-Ru(bpy)2(ppz)2+ with calf thymus DNA. J Phys Chem 97:1707–1711
Usman M, Arjmand F, Khan RA, Alsalme A, Ahmad M, Tabassumm S (2017) Biological evaluation of dinuclear copper complex/dichloroacetic acid cocrystal against human breast cancer: design, synthesis, characterization, DFT studies and cytotoxicity assays. RSC Adv. 7:47920–47932
Wolfe A, JrGH Shimer, Meehan T (1987) Polycyclic aromatic hydrocarbons physically intercalate into duplex regions of denautured DNA. Biochemistry 26:6392–6396
Xie ZJ, Yu Z, Chen YC, Lu GY, Guo ZJ, He WJ (2012) DNA cleavage behavior of a new p-xylyl spaced bisCu(BPA)Cl2 complex: the steric effect of a bulky p-xylyl-derived spacer. New J Chem 36:644–649
Xu XW, Li XJ, Zhan SH, Li YT, Wu ZY, Yan CW (2013) Synthesis and structure of a new tetracopper(II) complex bridged both oxamido and phenolato groups: cytotoxic activity, and reactivity towards DNA and BSA. J Mol Struct 1039:28–36
Yuan T, Weljie AM, Vogel HJ (1998) Tryptophan fluorescence quenching by methionine and selenomethionine residues of calmodulin: orientation of peptide and protein binding. Biochemistry 37:3187–3195
Zhao YM, Zhu JH, He WJ, Yang Z, Zhu YG, Li YZ, Zhang JF, Guo ZJ (2006) Oxidative DNA cleavage promoted by multinuclear copper complexes: activity dependence on the complex structure. Chem Eur J 12:6621–6629
Acknowledgements
We acknowledge the financial support from the Natural Science Foundation of Hubei Province (No. 2018CFB658) and the Opening Project of Key Laboratory of Optoelectronic Chemical Materials and Devices, Ministry of Education, Jianghan University (No. JDGD-201810).
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Chen, Z., Wu, Y., Zhu, Z. et al. DNA cleavage, DNA/HSA binding study, and antiproliferative activity of a phenolate-bridged binuclear copper(II) complex. Biometals 32, 227–240 (2019). https://doi.org/10.1007/s10534-019-00172-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10534-019-00172-w